Article Details
Retrieved on: 2022-10-18 17:19:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Q3 FY22 sales reached CHF14.74 billion, down 6% Y/Y due to lower sales from COVID-19 treatments and diagnostics. "The third quarter of 2022 was ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here